title: Varicella vaccine: case studies.
abstract: A live varicella vaccine (Oka strain) has been developed. Clinical trials in normal and high-risk children have been carried out successfully in Japan, the USA and Europe, leading to recent licensing of this vaccine in several countries. Characterization of the vaccine and the results of clinical trials are reviewed in this article.
authors.affiliation: Research Institute for Microbial Diseases, Osaka University, Japan.
authors.forename: M
authors.initials: M
authors.lastname: Takahashi
authors.forename: Y
authors.initials: Y
authors.lastname: Asano
authors.forename: H
authors.initials: H
authors.lastname: Kamiya
authors.forename: K
authors.initials: K
authors.lastname: Baba
mesh_terms: D000818:Animals; D000914:Antibodies, Viral / Q000096:biosynthesis; D002644:Chickenpox / Q000517:prevention & control; D019433:Chickenpox Vaccine; D002648:Child; D002675:Child, Preschool; D004311:Double-Blind Method; D005060:Europe; D014645:Herpesvirus 3, Human / Q000276:immunology* / Q000502:physiology; D006801:Humans; D007564:Japan; D014481:United States; D014765:Viral Vaccines
chemical_list: D000914:Antibodies, Viral; D019433:Chickenpox Vaccine; D014765:Viral Vaccines